Adel Galal El-Shemi1,2, Ahmad Mohammed Ashshi3, Youjin Na4, Yan Li5, Mohammed Basalamah3,6, Faisal Ahmad Al-Allaf7, Eonju Oh4, Bo-Kyeong Jung4, Chae-Ok Yun8. 1. Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, PO Box 7607, Holy Makkah, Saudi Arabia. dr_adel_elshemy2006@yahoo.com. 2. Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt. dr_adel_elshemy2006@yahoo.com. 3. Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, PO Box 7607, Holy Makkah, Saudi Arabia. 4. Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsinmi-ro, Seongdong-gu, Seoul, Korea. 5. Graduate Program for Nanomedical Science, Yonsei University, Seoul, Korea. 6. Department of Pathology, Faculty of Medicine, Umm Al-Qura University, Holy Makkah, Saudi Arabia. 7. Science and Technology Unit & Department of Medical Genetics,Faculty of Medicine, Umm Al-Qura University, Holy Makkah, Saudi Arabia. 8. Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsinmi-ro, Seongdong-gu, Seoul, Korea. chaeok@hanyang.ac.kr.
Unfortunately, the original version of this article [1] contained an error. One of the subheadings within the “Methods” section read “Generation and purification of oncolytic adenoviruses expressing humanTRAIL or humanING4 transgene”, but it should have read “Generation and purification of oncolytic adenoviruses expressing humanTRAIL or human IL-12 transgene”.This subheading has been also corrected in the original article.
Authors: Adel Galal El-Shemi; Ahmad Mohammed Ashshi; Youjin Na; Yan Li; Mohammed Basalamah; Faisal Ahmad Al-Allaf; Eonju Oh; Bo-Kyeong Jung; Chae-Ok Yun Journal: J Exp Clin Cancer Res Date: 2016-05-06